SENS’s Quality Factors
SENS has a Quality Grade of D, ranking ahead of 13.13% of graded US stocks.
Similarly, Is SENS a good buy right now?
The financial health and growth prospects of SENS, demonstrate its potential to underperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F.
What is the future of SENS stock? Stock Price Forecast
The 3 analysts offering 12-month price forecasts for Senseonics Holdings Inc have a median target of 2.50, with a high estimate of 6.00 and a low estimate of 0.80. The median estimate represents a +46.20% increase from the last price of 1.71.
Thereof, Is SENS undervalued?
The stock of Senseonics Holdings (AMEX:SENS, 30-year Financials) is believed to be significantly overvalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus’ estimate of the fair value at which the stock should be traded.
Is SENS FDA approved?
At long last, following a year of Covid delays, Sensonics (SENS) received the FDA’s nod of approval for its long-lasting continuous glucose monitoring system (CGM).
Will SENS get FDA approval?
Senseonics (NYSE:SENS) announced today that the FDA approved its next-generation continuous glucose monitor system, which lasts up to half a year.
Why is Sens stock dropping?
What happened. Shares of Senseonics Holdings ( SENS -0.55% ) were sinking 14.3% as of 3:12 p.m. EDT on Thursday. The big drop came after the medical technology company announced the pricing of a public offering of its stock.
Is the Eversense CGM available in Australia?
It will be some time before this system is available in Australia. The Eversense is the first of implantable CGM systems. The under-the-skin sensors last 90-days and would be inserted under local anaesthetic by your diabetes healthcare provider.
How much is Eversense?
Eversense pricing
They typically run between $200 to $300 for insertion and $300 to $400 for removal and reinsertion. But even with that, the annual cost of use — before insurance is factored in — is close to that of the competing Dexcom CGM. Estimated total: $6,400 per year, or $533 a month.
What is Sens news?
Stock Exchange News Service (SENS)
The JSE offers a service that provides the user with access to company announcements such as mergers, take-overs, rights offers, capital issues, cautionaries – all of which have a direct impact on the movement in the market. This service is called Stock Exchange news Service.
Is Senseonics a buy?
Senseonics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Is Senseonics a good stock to buy?
Senseonics Holdings Inc finds support from accumulated volume at $1.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested. This stock has average movements during the day and with good trading volume, the risk is considered to be medium.
Is Libre 2 available in Australia?
Abbott is pleased to announce its next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2 is now registered for use in Australia by adults and children (4 and older) with insulin-dependent diabetes, following review by the Therapeutic Goods Administration (TGA).
Is Control IQ available in Australia?
Tandem have made the decision to launch Control-IQ technology in both Australia and New Zealand with the features and benefits of the latest version of software.
How long do continuous glucose monitors last?
For most devices, you change sensors at home every 7 to 14 days. For some long-term implantable CGM devices, your healthcare provider will change the sensor in a procedure in their office a handful of times (or less) each year.
Is Eversense better than Dexcom?
Conclusions: The point accuracy of the Eversense was better than two other CGMs when compared with POC PG values. Keywords: Abbott Libre; Accuracy; Continuous glucose monitoring; Dexcom G5; Senseonics Eversense.
How long does Eversense transmitter last?
Eversense Sensor
The sensor is inserted under the skin (upper arm) and measures glucose in interstitial fluid for up to 90 days. These glucose levels are then calculated by the smart transmitter and sent to the app. The Eversense Sensor lasts up to 90 days.
What does Eversense mean?
About Eversense
The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. It is intended to complement, not replace, fingerstick blood glucose monitoring.
What does Sens company do?
Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community.
What sector is Sens in?
Key Data
| Label | Value |
|---|---|
| Exchange | AMEX |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| 1 Year Target | $3.00 |
How many shares does Sens have?
Share Statistics
| Avg Vol (3 month) 3 | 13.61M |
|---|---|
| Shares Outstanding 5 | 463.15M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 333.03M |
| % Held by Insiders 1 | 9.91% |
Is SENS a hold?
Senseonics Holdings, Inc. is a company in the U.S. stock market and it is a holding in 30 U.S.-traded ETFs. SENS has around 29.7M shares in the U.S. ETF market.
Who is buying SENS stock?
Top 10 Owners of Senseonics Holdings Inc
| Stockholder | Stake | Shares bought / sold |
|---|---|---|
| Geode Capital Management LLC | 1.45% | +353,248 |
| Susquehanna Financial Group LLLP | 0.99% | -163,686 |
| Northern Trust Investments, Inc.(… | 0.90% | +5,382 |
| Citadel Advisors LLC | 0.67% | +2,986,650 |
How high does IDEX go?
IDEX stock hit a 2022 high of $1.44 in early January and a low of $0.87 later in the same month. In 2021 its stock price ranged from 88 cents to $5.53. In an interview with Capital.com, Vinod Jain, senior analyst at Aite-Novarica Group, said “the stock could see more volatility due to its current price point”.
Join TheMoney.co community and don’t forget to share this post !
